Efficacy and predictive factors of venetoclax combined with azacitidine as salvage therapy in advanced acute myeloid leukemia patients: A multicenter retrospective study

Leuk Res. 2020 Apr:91:106317. doi: 10.1016/j.leukres.2020.106317. Epub 2020 Feb 14.

¹ Department of Hematology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, PR China.
² Department of Hematology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China.
³ Department of Hematology, the Ningbo Yinzhou People's Hospital, Ningbo, PR China.
⁴ Department of Hematology, Shulan Hospital, Hangzhou, PR China.
⁵ Department of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou, PR China.
⁶ Department of Hematology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, PR China. Electronic address: jiej0503@zju.edu.cn.

No abstract available

Publication types